# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1247296 | A | Cytotoxicity against human HeLa cells after 3 days by XTT assay | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
2. | ALA1247297 | A | Cytotoxicity against human HeLa cells assessed as maximum non-cytotoxic concentration after 3 days by XTT assay | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
3. | ALA1247298 | F | Antiviral activity against Human rhinovirus 1B infected in human HeLa cells after 3 days by plaque reduction assay | Human rhinovirus 1B | 17 | organism-based format | Scientific Literature | ||
4. | ALA1247299 | A | Therapeutic index, ratio of TC50 for human HeLa cells to IC50 for HRV 1B | 16 | cell-based format | Scientific Literature | |||
5. | ALA1247300 | F | Antiviral activity against Human rhinovirus 14 infected in human HeLa cells after 3 days by plaque reduction assay | rhinovirus B14 | 16 | organism-based format | Scientific Literature | ||
6. | ALA1247302 | A | Therapeutic index, ratio of TC50 for human HeLa cells to IC50 for HRV 14 | 9 | cell-based format | Scientific Literature | |||
7. | ALA1247303 | A | Cytotoxicity against human Hep2 cells assessed as maximum non-cytotoxic concentration after 3 days by XTT assay | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
8. | ALA1247304 | F | Antiviral activity against Human enterovirus 71 infected in human Hep2 cells after 2 days by plaque reduction assay | Enterovirus A71 | 17 | organism-based format | Scientific Literature | ||
9. | ALA1247305 | F | Antiviral activity against Human enterovirus 71 infected in human Hep2 cells at maximum non-cytotoxic concentration after 3 days by plaque reduction assay | Enterovirus A71 | 17 | organism-based format | Scientific Literature |